Evidence map›Paper›PMID 32116427›Full record

ArticleEthiopian journal of health sciences2020

Levels of Blood Biomarkers among Patients with Myocardial Infarction in Comparison to Control Group.

Amir Shamshirian, Reza Alizadeh-Navaei, Samira Abedi, Hamed Jafarpour, Hanieh Fazli, Samira Hosseini, Amirhossein Hessami, Keyvan Karimifar, Sedighe Yosefi, Mohammad Zahedi and 11 more

Open access · diamondAbstract read
In one paragraph

Article in Ethiopian journal of health sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 12 citations in OpenAlex.

  1. Cardioprotective Potential of Aqueous Extract ofOxidative medicine and cellular longevity · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 4 institutions in 1 country.

Amir ShamshirianDepartment of Medical Laboratory Sciences, School of Allied Medical sciences, Mazandaran University of Medical Sciences, Iran.
Reza Alizadeh-NavaeiGastrointestinal Cancer Research Center, Mazandaran University of Medical Sciences, Iran.
Samira AbediStudent Research Committee, School of Medicine, Mazandaran University of Medical Sciences, Iran.
Hamed JafarpourStudent Research Committee, School of Medicine, Mazandaran University of Medical Sciences, Iran.
Hanieh FazliStudent Research Committee, School of Medicine, Mazandaran University of Medical Sciences, Iran.
Samira HosseiniDepartment of Medical Laboratory Sciences, School of Allied Medical sciences, Mazandaran University of Medical Sciences, Iran.
Amirhossein HessamiStudent Research Committee, School of Medicine, Mazandaran University of Medical Sciences, Iran.
Keyvan KarimifarStudent Research committee, Mashhad University of Medical Sciences, Mashhad, Iran.
Sedighe YosefiDepartment of Biochemistry, Faculty of Medicine, Semnan University of Medical Sciences, Semnan, Iran.
Mohammad ZahediDepartment of Medical Laboratory Sciences, School of Allied Medical sciences, Mazandaran University of Medical Sciences, Iran.
Sepideh MotamenDepartment of Medical Biotechnology, Faculty of Medical Sciences, Tarbiat Modares University, Iran.
Atiyeh GhorbanpourDepartment of Hematology, Student Research Committee, Iran University of Medical Sciences, Iran.
Bahman ZarandiDepartment of Hematology, Student Research Committee, Iran University of Medical Sciences, Iran.
Aliakbar EsfahaniStudent Research committee, Mashhad University of Medical Sciences, Mashhad, Iran.
Yeganeh Rostamian-MoghaddamBlood Transfusion Research Center, Mazandaran Blood Transfusion Center, Sari, Iran.
Shirin MehdipourMazandaran Heart Center, Mazandaran University of Medical Sciences, Iran.
Keyvan HeydariStudent Research Committee, School of Medicine, Mazandaran University of Medical Sciences, Iran.
Sedigheh AghajanianDepartment of Medical Laboratory Sciences, School of Allied Medical sciences, Mazandaran University of Medical Sciences, Iran.
Somayeh Pour MehdiMazandaran Heart Center, Mazandaran University of Medical Sciences, Iran.
Alireza AzadMazandaran Heart Center, Mazandaran University of Medical Sciences, Iran.
Soheil AziziDepartment of Medical Laboratory Sciences, School of Allied Medical sciences, Mazandaran University of Medical Sciences, Iran.
Mazandaran University of Medical Sciences · IRMashhad University of Medical Sciences · IRSemnan University of Medical Sciences · IRTarbiat Modares University · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMyocardial infarction (MI) as a term for a heart attack happens due to reduced blood flow to heart myocardium and lack of oxygen supply caused by plaques in the interior walls of coronary arteries. With respect to the importance of MI etiology, we aimed to study the relationship of MI and blood examination variables.

methodsThis study was conducted in Mazandaran Heart Center as a hospital-based case-control Comprising 894 participants including 465 cases and 429 controls, individually matched by sex and age. Considered blood markers were analyzed using routine laboratory methods and equipment.

resultsOf all participants, 64.3% of the cases and 51.0% of the controls were males with a mean age of 61.2 (±13.8) in cases and 62.4 (±14.) in controls. We could not find any differences between cases and controls for total cholesterol (TC), low-density lipoprotein (LDL), high-density lipoprotein (HDL), and alkaline-phosphatase (ALP) (P>0.05). However, levels of creatine-kinase-muscle/brain (CK-MB) (P<0.0001), fasting-blood-sugar (FBS) (P<0.0001), aspartate-aminotransferase (AST) (P<0.0001), alanine-transferase (ALT) (P<0.0001) and erythrocyte sedimentation rate (ESR) (P=0.001) were significantly higher in cases compared to the controls (P<0.05). Multivariable analyses revealed that the risk of MI was associated with high levels of AST (adjusted OR=24.3, 95%CI=3.5±165.6, P=0.001) and LDL (adjusted OR=7.4, 95%CI=1.0±51.8, P=0.001).

conclusionOur investigation indicated that the levels of CK-MB, FBS, AST, ALT and ESR were significantly higher in patients with MI. Besides, our findings showed that the risk of MI in cases with high levels of AST and LDL was about 24 and 7 times more than the control group respectively.

Indexed as

Blood SedimentationAgedAlanine TransaminaseAlkaline PhosphataseAspartate AminotransferasesBiomarkersBlood GlucoseCase-Control StudiesCholesterolCholesterol, HDLCholesterol, LDLCreatine Kinase, MB FormFastingFemaleHumansMaleAlanine TransaminaseAlkaline PhosphataseAspartate AminotransferasesBiomarkersBlood GlucoseCholesterolCholesterol, HDLCholesterol, LDLCreatine Kinase, MB FormBiochemical MarkersCardiovascular StrokeHeart AttackLaboratory MarkersSerum Marker

Identifiers

PMID32116427
PMCPMC7036464
OpenAlexW3007456688

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.